Omeprazole does not treat colitis and is not used to manage it. In fact, growing evidence suggests that proton pump inhibitors like omeprazole may worsen outcomes for people with inflammatory bowel disease and can even trigger a specific form of colitis on their own. If you’re taking omeprazole alongside a colitis diagnosis, it’s worth understanding how the drug interacts with your condition.
Why Omeprazole Doesn’t Target Colitis
Omeprazole works by shutting down acid-producing pumps in the stomach lining. This makes it effective for acid reflux, ulcers, and other conditions where stomach acid is the problem. Colitis, whether ulcerative colitis or microscopic colitis, involves inflammation in the colon, which is far downstream from where omeprazole acts. The drug has no anti-inflammatory effect on colonic tissue and no mechanism for reducing the immune-driven damage that characterizes colitis.
The confusion likely arises because many people with colitis also take omeprazole for a separate reason. About 23% of people with ulcerative colitis also have gastroesophageal reflux disease, compared to 16.5% of the general population. So omeprazole is commonly co-prescribed, but it’s treating the reflux, not the colitis.
How Omeprazole Can Make Colitis Worse
The more concerning finding is that omeprazole may actively harm people with colitis. A meta-analysis covering nearly 100,000 subjects found that inflammatory bowel disease patients taking proton pump inhibitors had significantly worse outcomes than those who weren’t. For ulcerative colitis specifically, PPI users had a 38% higher rate of adverse outcomes like hospitalization and surgery. They also needed steroid medications more often, suggesting more frequent or more severe flares.
The likely explanation involves the gut microbiome. Omeprazole raises the pH throughout the digestive tract, not just in the stomach. This disrupts the acid barrier that normally prevents oral bacteria from colonizing the intestines. In PPI users, potentially harmful bacteria like E. coli, Streptococcus, Staphylococcus, and Enterococcus increase significantly, while beneficial species like Bifidobacterium decline. The increase in certain bacteria, particularly in the Escherichia-Shigella group, is considered a hallmark of colitis development and correlates with higher levels of inflammatory signaling in the gut.
Both PPI users and IBD patients already share a common problem: reduced diversity in their gut bacteria. Adding omeprazole to an already disrupted microbiome may compound the imbalance. Changes in colonic pH alone can account for anywhere from 3% to 67% of the variation in gut bacteria composition, which is a remarkably wide range that underscores how sensitive the colon’s ecosystem is to pH shifts.
Omeprazole as a Cause of Microscopic Colitis
Omeprazole doesn’t just worsen existing colitis. It’s one of the most strongly linked drugs to a condition called microscopic colitis, a form of colitis where the colon looks normal on a standard colonoscopy but shows inflammation under a microscope. The main symptom is chronic, watery diarrhea.
A large Danish case-control study found that current PPI use was associated with a nearly sevenfold increased risk of collagenous colitis (one subtype) and a nearly fourfold increased risk of lymphocytic colitis (the other subtype). This association held across all proton pump inhibitors, not just omeprazole. If you’ve developed persistent watery diarrhea after starting omeprazole, drug-induced microscopic colitis is a real possibility. In many cases, symptoms resolve after stopping the medication.
Does It Interfere With Colitis Medications?
One reasonable concern is whether omeprazole disrupts the delivery of mesalamine, one of the most common medications for ulcerative colitis. Many mesalamine formulations use a pH-sensitive coating designed to dissolve only when the pill reaches the colon. Since omeprazole raises pH throughout the gut, there’s a theoretical risk that the coating could dissolve too early, releasing the drug before it reaches its target.
Fortunately, this doesn’t appear to happen in practice. A study testing omeprazole at both standard and high doses found no significant change in how mesalamine was absorbed or excreted. The amount of active drug reaching the colon stayed the same regardless of omeprazole use. So while omeprazole may affect colitis through the microbiome, it doesn’t seem to sabotage the medications used to treat it.
When Omeprazole Is Still Necessary
None of this means you should stop omeprazole abruptly if you have colitis. If you’re taking it for documented reflux, Barrett’s esophagus, or another acid-related condition, the benefit may outweigh the risks. The key is making sure the prescription is still justified. Many people remain on PPIs long after the original reason has resolved, and for someone with colitis, that unnecessary exposure carries real downsides.
If you’re experiencing worsening colitis symptoms or new-onset watery diarrhea while on omeprazole, the medication itself could be contributing. Lower-risk alternatives for acid suppression exist, and in some cases, lifestyle changes can reduce or eliminate the need for acid-suppressing drugs altogether. The decision depends on balancing your reflux symptoms against the potential gut microbiome disruption, something best worked through with the prescriber managing your colitis.